GlassScriptPhysician profile
Christy L Stevens
NPI 1578507950
$2,933.86
in general payments reported to CMS, 2019-2025
28 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $142 · 2021: $260 · 2022: $1,238 · 2023: $396 · 2024: $342 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.16 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $529.01 | 2022 | |
| Astellas Pharma US INC | $393.49 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $386.60 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $209.61 | 2021-2025 | |
| Exeltis, USA INC. | $189.35 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $189.00 | 2019-2023 | Balcoltra |
| Pfizer INC. | $171.72 | 2019-2023 | |
| Myovant Sciences INC. | $148.93 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $99.00 | 2023-2025 | Myfembree |
| Ethicon US, LLC | $81.40 | 2021 | |
| Boston Scientific Corporation | $56.88 | 2025 | General - Female Sui |
| Organon LLC | $52.34 | 2024-2025 | Nexplanon |
| Xeris Pharmaceuticals, INC. | $40.33 | 2024-2025 | Gvoke Hypopen |
| Amgen INC. | $36.21 | 2019 | |
| Hologic Sales and Service, LLC | $35.61 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $35.52 | 2019-2022 | |
| Duchesnay USA Incorporated | $35.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.34 | 2019 | |
| Sage Therapeutics, LLC | $31.95 | 2024 | |
| Merck Sharp & Dohme LLC | $29.76 | 2019-2025 | Gardasil 9 |
| Minerva Surgical, INC | $27.30 | 2022-2024 | |
| Axonics, INC. | $24.68 | 2023 | Axonics |
| Applied Medical Resources Corporation | $22.33 | 2023 | |
| Novo Nordisk INC | $17.86 | 2023 | Wegovy |
| Roche Diagnostics Corporation | $16.62 | 2021 | |
| Shield Therapeutics INC | $15.67 | 2024 | |
| Allergan, INC. | $12.91 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.